Her friend won t get the vaccine A COVID expert asked Twitter: How do I sway her? thereporteronline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thereporteronline.com Daily Mail and Mail on Sunday newspapers.
The Washington State Department of Health (DOH) announced Tuesday it is investigating reports of people who tested positive for COVID more than two weeks after being fully vaccinated against the disease.
According to Kiro 7 News, a CBS affiliate in Washington, the DOH is investigating reports of the so-called “breakthrough cases,” which it said are expected with any vaccine. Each case was confirmed with a polymerase chain reaction (PCR) test or a positive antigen test more than two weeks after the person had been fully vaccinated.
A majority of people with confirmed vaccine breakthrough experienced mild symptoms, if any. However, since Feb. 1, eight people with vaccine breakthrough cases were hospitalized and the DOH “is investigating two potential vaccine breakthrough cases where the patients died. Both patients were more than 80 years old and suffered underlying health issues,” officials said in a press release.
Hospitals see rare COVID-19 cases in fully vaccinated patients live5news.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from live5news.com Daily Mail and Mail on Sunday newspapers.
Roper St. Francis Hospital becomes testing ground for new potential COVID-19 treatments
VIDEO: Roper St. Francis Hospital becomes testing ground for new potential COVID-19 treatments By Kaitlin Stansell | January 13, 2021 at 5:10 PM EST - Updated January 13 at 7:43 PM
CHARLESTON, S.C. (WCSC) - A Lowcountry hospital was selected to be among ten sites across the country to test a new and promising coronavirus treatment.
Roper St. Francis Hospital experimented with an antibody therapy called CERC-002 that has shown positive impacts for patients who are hospitalized with complications caused by COVID-19.
CERC is a LIGHT-neutralizing antibody therapy that directs a patient’s immune system to respond to the infection in a way that reduces further inflammation.